X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (144) 144
female (116) 116
hematology (116) 116
male (111) 111
adult (108) 108
index medicus (106) 106
middle aged (105) 105
transplantation (89) 89
aged (69) 69
transplantation, homologous (67) 67
adolescent (60) 60
stem cells (54) 54
retrospective studies (53) 53
oncology (46) 46
treatment outcome (46) 46
immunology (43) 43
bone-marrow-transplantation (38) 38
leukemia (38) 38
recurrence (38) 38
survival (38) 38
hematopoietic stem cells (37) 37
hematopoietic stem cell transplantation (36) 36
young adult (35) 35
hematopoietic stem cell transplantation - adverse effects (32) 32
hematopoietic stem cell transplantation - methods (31) 31
stem cell transplantation (31) 31
leukemia, myeloid, acute - therapy (30) 30
risk factors (29) 29
bone marrow (28) 28
prognosis (28) 28
stem-cell transplantation (28) 28
acute myeloid-leukemia (26) 26
analysis (25) 25
versus-host-disease (24) 24
cancer (23) 23
survival rate (23) 23
survival analysis (22) 22
acute myeloid leukemia (21) 21
disease-free survival (21) 21
allogeneic stem cell transplantation (20) 20
leukemia, myeloid, acute - mortality (20) 20
transplantation conditioning - methods (20) 20
unrelated donors (20) 20
blood (19) 19
child (19) 19
myelodysplastic syndromes - therapy (19) 19
tissue donors (19) 19
research (18) 18
bone marrow transplantation (17) 17
chemotherapy (17) 17
hematology, oncology and palliative medicine (17) 17
patients (17) 17
relapse (17) 17
health aspects (16) 16
leukemia, myelogenous, chronic, bcr-abl positive - therapy (16) 16
abridged index medicus (15) 15
graft vs host disease - etiology (15) 15
hematopoietic stem cell transplantation - mortality (15) 15
mortality (15) 15
myelodysplastic syndrome (15) 15
prospective studies (15) 15
risk (15) 15
therapy (15) 15
transplants & implants (15) 15
acute disease (14) 14
adults (14) 14
allografts (14) 14
myelodysplastic syndromes - mortality (14) 14
care and treatment (13) 13
chronic myelogenous leukemia (13) 13
follow-up studies (13) 13
graft vs host disease - prevention & control (13) 13
multivariate analysis (13) 13
surgery (13) 13
transplantation conditioning (13) 13
bone-marrow (12) 12
fludarabine (12) 12
incidence (12) 12
marrow-transplantation (12) 12
mds (12) 12
myeloid leukemia (12) 12
patient outcomes (12) 12
aml (11) 11
hematologic neoplasms - therapy (11) 11
recipients (11) 11
usage (11) 11
acute lymphoblastic-leukemia (10) 10
acute myelogenous leukemia (10) 10
article (10) 10
child, preschool (10) 10
cyclophosphamide (10) 10
expression (10) 10
graft-versus-host reaction (10) 10
hematologic malignancies (10) 10
life sciences (10) 10
myelodysplastic syndromes (10) 10
remission (10) 10
remission induction (10) 10
siblings (10) 10
allogeneic transplantation (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 3, pp. 440 - 446
Journal Article
Blood, ISSN 0006-4971, 10/2010, Volume 116, Issue 14, pp. 2438 - 2447
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 10/2016, Volume 17, Issue 11, pp. 1797 - 1797
Natural killer (NK) cells play a central role in the innate immune system. In allogeneic stem cell transplantation (alloSCT), alloreactive NK cells derived by... 
Graft-versus-host disease | NK cells | NKG2C receptor | Allogeneic stem cell transplantation | RECOGNITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOLECULE HLA-E | GVHD | SELF | LEUKEMIA RELAPSE | CHEMISTRY, MULTIDISCIPLINARY | allogeneic stem cell transplantation | KIR | COMPLEX CLASS-I | BIOLOGY | RECONSTITUTION | graft-versus-host disease | Lymphoma, Non-Hodgkin - immunology | NK Cell Lectin-Like Receptor Subfamily C - biosynthesis | Humans | Middle Aged | Immunity, Innate - genetics | Male | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Lymphoma, Non-Hodgkin - pathology | NK Cell Lectin-Like Receptor Subfamily D - immunology | NK Cell Lectin-Like Receptor Subfamily C - immunology | NK Cell Lectin-Like Receptor Subfamily D - biosynthesis | Myelodysplastic Syndromes - therapy | Killer Cells, Natural - immunology | Adult | Female | Leukemia, Myeloid, Acute - therapy | Transplantation, Homologous - adverse effects | Leukemia, Myeloid, Acute - pathology | Histocompatibility Antigens Class I - immunology | Graft vs Host Disease - pathology | Lymphoma, Non-Hodgkin - therapy | Graft vs Host Disease - prevention & control | Aged | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - immunology | Stem Cell Transplantation - adverse effects | Leucocytes | Transplants & implants | Skin & tissue grafts | Leukemia | Stem cells | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1035 - 1044
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 04/2019, Volume 20, Issue 7, p. 1642
Treatment with extracellular vesicles (EVs) derived from mesenchymal stem/stromal cells (MSCs) have been suggested as novel therapeutic option in acute... 
CELLS | mesenchymal stem | BIOCHEMISTRY & MOLECULAR BIOLOGY | EXOSOMES | Graft-versus-Host-Disease (GvHD) | VERSUS-HOST-DISEASE | CHEMISTRY, MULTIDISCIPLINARY | stromal cells (MSC) | extracellular vesicles (EV) | mesenchymal stem/stromal cells (MSC)
Journal Article
Journal Article
Critical Care, ISSN 1364-8535, 03/2017, Volume 21, Issue 1, p. 70
Background: Impaired gastric emptying is common in critically ill patients. Intestinal dysmotility, a major cause of feed intolerance, may foster infectious... 
T lymphocytes | Gastric emptying | Intensive care | Gut homing | Critically ill | Mucosal barrier | CELLS | POSTOPERATIVE ILEUS | CRITICAL ILLNESS | MULTIPLE ORGAN FAILURE | ENTERAL NUTRITION | ACID-BINDING PROTEIN | MOUSE MODEL | PARENTERAL-NUTRITION | ABSORPTION | EXPRESSION | CRITICAL CARE MEDICINE | Intestinal Diseases - complications | Prospective Studies | Humans | Middle Aged | Receptors, CCR - blood | Tumor Necrosis Factor-alpha - blood | Interleukin-10 - blood | Intensive Care Units - statistics & numerical data | Male | CD4-Positive T-Lymphocytes - pathology | Interleukin-1beta - blood | Receptors, CCR - analysis | Critical Illness - mortality | Adult | Female | Interleukin-10 - analysis | Severity of Illness Index | Interleukin-1beta - analysis | Biomarkers - analysis | Enteral Nutrition | Intensive Care Units - organization & administration | Tumor Necrosis Factor-alpha - analysis | Intestinal Diseases - diagnosis | Gastric Emptying - physiology | Respiration, Artificial - statistics & numerical data | Organ Dysfunction Scores | ROC Curve | Aged | APACHE | Motility | Transplants & implants | Cytokines | Nutrition | Parenteral nutrition | Patients | Fatty acids | Small intestine | Blood | Proteins | Illnesses | Analgesics | Lymphocytes | Rodents | Gastroenterology | Sepsis | Tumor necrosis factor-TNF | Ventilation
Journal Article
Annals of Hematology, ISSN 0939-5555, 03/2019, Volume 98, Issue 3, pp. 811 - 811
The author name Philipp Wohlfarth was incorrectly spelled as Philipp Wohlfahrth in the original version of this article. 
Journal Article
Haematologica, ISSN 0390-6078, 10/2012, Volume 97, Issue 10, pp. 1523 - 1531
Journal Article
Cancer, ISSN 0008-543X, 07/2017, Volume 123, Issue 14, pp. 2671 - 2679
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for patients with acute myeloid leukemia (AML). However, post‐HCT relapse... 
toxicity | graft‐versus leukemia effect | treosulfan | allogeneic stem cell transplantation | conditioning regimen | acute myeloid leukemia | graft-versus leukemia effect | TOTAL-BODY IRRADIATION | MYELOABLATIVE REGIMEN | REDUCED INTENSITY | INTRAVENOUS BUSULFAN | MYELODYSPLASTIC SYNDROME | NONMALIGNANT DISEASES | BRONCHIOLITIS OBLITERANS | ALLOGENEIC HEMATOPOIETIC SCT | ONCOLOGY | HEPATIC VENOOCCLUSIVE DISEASE | STEM-CELL TRANSPLANTATION | Myeloablative Agonists - therapeutic use | Busulfan - analogs & derivatives | Graft vs Host Disease - epidemiology | Humans | Middle Aged | Male | Cause of Death | Alkylating Agents - therapeutic use | Young Adult | Adult | Female | Registries | Retrospective Studies | Transplantation Conditioning - methods | Leukemia, Myeloid, Acute - therapy | Busulfan - therapeutic use | Survival Rate | Treatment Outcome | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Antineoplastic Agents, Alkylating - therapeutic use | Disease-Free Survival | Aged | Hematopoietic Stem Cell Transplantation - methods | Cancer patients | Usage | Stem cells | Dosage and administration | Transplantation | Health aspects | Immunosuppressive agents | Slopes | Graft-versus-host reaction | Toxicity | Syngeneic grafts | Leukemia | Risk | Treosulfan | Grafting | Blood | Alkylation | Incidence | Anticancer properties | Veno-occlusive disease | Infusion | Allografts | Peripheral blood | Bone marrow | Remission | Toxic diseases | Conditioning | Age | Siblings | Myeloid leukemia | Mortality | Alkylating agents | Health risks | Patients | Survival | Ablation | Immunosuppression | Fludarabine | Donors | Fatalities | Histocompatibility antigen HLA | Acute myeloid leukemia | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5775 - 5775
Abstract Introduction Allogeneic hematopoietic stem cell transplantation (alloSCT) is curative therapy for chronic myeloid leukemia (CML), but its long-term... 
Journal Article
Bone marrow transplantation, ISSN 0268-3369, 08/2019
The success of allogeneic hematopoietic stem cell transplantation (alloSCT) is indicated by the reconstitution of the peripheral blood system of patients after... 
Journal Article
Journal Article